FDA sceptical about link between breast cancer and the pill
Ezzell, C.
Nature 337(6203): 108
1989
ISSN/ISBN: 0028-0836 PMID: 2911340 DOI: 10.1038/337108b0Document Number: 371102
Document emailed within 0-6 h
Related Documents
Richard Lincoln 1984: FDA Committee: No Support for Pill-Breast Cancer Link, But Cervical Cancer Connection More Ambiguous International Family Planning Perspectives 10(1): 27-31Gever, M.P. 1998: Estrogen and Breast Cancer: Is there a Link? International Journal of Pharmaceutical Compounding 2(1): 21-23
&Na;, 1986: No Link Between Breast Cancer and Oral Contraceptives Journal of Wound, Ostomy and Continence Nursing 13(4): 33A-34A
Lincoln, R. 1984: The pill, breast and cervical cancer, and the role of progestogens in arterial disease Family Planning Perspectives 16(2): 55-63
Lipkus, I.M.; Iden, D.; Terrenoire, J.; Feaganes, J.R. 1999: Relationships among breast cancer concern, risk perceptions, and interest in genetic testing for breast cancer susceptibility among African-American women with and without a family history of breast cancer Cancer Epidemiology Biomarkers and Prevention: a Publication of the American Association for Cancer Research Cosponsored by the American Society of Preventive Oncology 8(6): 533-539
Owens, R.L. 2016: Better Sleep in the Intensive Care Unit: Blue Pill or Red Pill… or no Pill? Anesthesiology 125(5): 835-837
Owens, R.L. 2016: Better Sleep in the Intensive Care Unit: Blue Pill or Red Pill… or no Pill? Anesthesiology 125(5): 835-837
Owens, R.L. 2016: Better Sleep in the Intensive Care Unit: Blue Pill or Red Pill… or no Pill? Anesthesiology 125(5): 835-837
Owens, R.L. 2016: Better Sleep in the Intensive Care Unit: Blue Pill or Red Pill… or no Pill? Anesthesiology 125(5): 835-837
1997: Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases. Breast Cancer Linkage Consortium Lancet 349(9064): 1505-1510
Lachenicht, L. 1993: A Sceptical Argument concerning the Value of a Behavioural Solution for AIDS South African Journal of Psychology 23(1): 15-20
Drife, J.O. 1984: The pill and the breast Ippf Medical Bulletin 18(6): 1-2
Briggs, P.; Serrani, M.; Vogtländer, K.; Parke, S. 2016: Continuation rates, bleeding profile acceptability, and satisfaction of women using an oral contraceptive pill containing estradiol valerate and dienogest versus a progestogen-only pill after switching from an ethinylestradiol-containing pill in a real-life setting: results of the CONTENT study International Journal of Women's Health 8: 477-487
Briggs, P.; Serrani, M.; Vogtländer, K.; Parke, S. 2016: Continuation rates, bleeding profile acceptability, and satisfaction of women using an oral contraceptive pill containing estradiol valerate and dienogest versus a progestogen-only pill after switching from an ethinylestradiol-containing pill in a real-life setting: results of the CONTENT study International Journal of Women's Health 8: 477-487
Reiner, A.S.; Sisti, J.; John, E.M.; Lynch, C.F.; Brooks, J.D.; Mellemkjær, L.; Boice, J.D.; Knight, J.A.; Concannon, P.; Capanu, M.; Tischkowitz, M.; Robson, M.; Liang, X.; Woods, M.; Conti, D.V.; Duggan, D.; Shore, R.; Stram, D.O.; Thomas, D.C.; Malone, K.E.; Bernstein, L.; Bernstein, J.L. 2018: Breast Cancer Family History and Contralateral Breast Cancer Risk in Young Women: An Update From the Women's Environmental Cancer and Radiation Epidemiology Study Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 36(15): 1513-1520
Nabholtz, J.M.; Lindsay, M.A.; Hugh, J.; Mackey, J.; Smylie, M.; Au, H.J.; Tonkin, K.; Allen, M. 1999: The academic global virtual concept in clinical cancer research and its application to breast cancer: The Breast Cancer International Research Group Seminars in Oncology 26(3 Suppl. 8): 4-8
Albeshan, S.M.; Hossain, S.Z.; Mackey, M.G.; Brennan, P.C. 2020: Can Breast Self-examination and Clinical Breast Examination Along with Increasing Breast Awareness Facilitate Earlier Detection of Breast Cancer in Populations with Advanced Stages at Diagnosis? Clinical Breast Cancer 20(3): 194-200
Rosenberg, L.; Palmer, J.R.; Shapiro, S. 1992: Oestrogen replacement therapy and breast cancer Results from the Slone Epidemiology Units Toronto Breast Cancer Study Mann, R D Hormone replacement therapy and breast cancer risk : 253-264
Mariuzzi, L.; Mombello, A.; Rucco, V.; Morelli, L.; Zamò, A.; Thompson, D.; Vaught, L.; Bartels, H.G.; Mariuzzi, G.; Bartels, P.H. 2000: Quantitative study of ductal breast cancer progression: signatures of nuclei in proliferating breast lesions and in situ cancer Advances in Clinical Pathology: the Official Journal of Adriatic Society of Pathology 4(2): 87-97
Stamatovic, L.; Susnjar, S.; Gavrilovic, D.; Minic, I.; Ursulovic, T.; Dzodic, R. 2018: The influence of breast cancer subtypes on the response to anthracycline neoadjuvant chemotherapy in locally advanced breast cancer patients Journal of Buon: Official Journal of the Balkan Union of Oncology 23(5): 1273-1280